Stocks making big moves this week: Bally's, Adobe, Novavax, Semtech, and STAAR Surgical

Several companies made notable moves this week as corporate developments and sector sentiment drove investor attention. Bally’s Corporation (NYSE:BALY) rose 11.6% on Thursday, extending its rally after reports said the gaming, betting and entertainment company is weighing a sale of development rights for its roughly $1.1 billion mixed-use project around the Athletics’ future Las Vegas ballpark. The potential monetization is the key catalyst behind the move. Adobe (NASDAQ:ADBE) gained 4.5% on Tuesday after asset-management giant BlackRock increased its stake in the creative software company to more than 10%. The change in ownership provided a positive signal for investors. Novavax (NASDAQ:NVAX) climbed 6.9% on Wednesday as positive trial results from peers Moderna and Merck for their personalized cancer vaccine improved sentiment across the vaccine sector. The move reflected a sector read-through rather than a company-specific trial announcement from Novavax. Semtech (NASDAQ:SMTC) advanced 9.3% on Monday after announcing the sale of its cellular module business for $62 million. The semiconductor company said the transaction would sharpen its focus on high-growth areas such as AI data-center networking, giving investors a clearer view of its strategic direction. STAAR Surgical (NASDAQ:STAA) fell 8.3% on Monday as sentiment weakened following the medical lens company’s underwhelming second-quarter earnings, reported the previous week. The decline left investors assessing the implications of that performance for the shares. Together, the moves highlight several market catalysts: potential asset monetization at Bally’s, institutional ownership changes at Adobe, peer-driven biotechnology sentiment at Novavax, portfolio reshaping at Semtech and earnings disappointment at STAAR Surgical.